	US 12,440,464 B2
	Method for treating respiratory viral infections comprising administration of fatty acid compositions
Marco A. Chacon, Annapolis, MD (US)
Assigned to Irazu Bio, Baltimore, MD (US)
Appl. No. 17/997,604
Filed by Irazu Bio, Baltimore, MD (US)
PCT Filed Apr. 29, 2021, PCT No. PCT/US2021/029841 § 371(c)(1), (2) Date Oct. 31, 2022, PCT Pub. No. WO2021/222535, PCT Pub. Date Nov. 4, 2021.
Claims priority of provisional application 63/019,009, filed on May 1, 2020.
Prior Publication US 2023/0218556 A1, Jul. 13, 2023
Int. Cl. A61K 31/201 (2006.01); A61K 9/107 (2006.01); A61K 31/20 (2006.01); A61K 45/06 (2006.01); A61P 11/00 (2006.01); A61P 29/00 (2006.01); A61P 31/14 (2006.01)

CPC A61K 31/201 (2013.01) [A61K 9/107 (2013.01); A61K 31/20 (2013.01); A61K 45/06 (2013.01); A61P 11/00 (2018.01); A61P 29/00 (2018.01); A61P 31/14 (2018.01)]

17 Claims

1. A method for treating a subject suffering from acute respiratory distress syndrome (ARDS) comprising administering a composition comprising an effective amount of a free fatty acid, a derivative thereof, or a combination thereof to a subject in need,

wherein the composition comprises a combination of oleic acid, linoleic acid, and

palmitic acid; and

wherein the subject is suffering from a viral infection.